Monitor tumor burden with circulating tumor DNA
Author:
Publisher
Informa UK Limited
Subject
Cancer Research,Pharmacology,Oncology,Molecular Medicine
Link
http://www.tandfonline.com/doi/pdf/10.4161/cbt.25361
Reference8 articles.
1. Validation of Analytic Methods for Biomarkers Used in Drug Development
2. Protein biomarker discovery and validation: the long and uncertain path to clinical utility
3. Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context
4. Tumor markers: Value and limitations in the management of cancer patients
5. Unbiased and Automated Identification of a Circulating Tumour Cell Definition That Associates with Overall Survival
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Basic ctDNA Panel Promises Affordable Clinical Validity in Colon Cancer Patients but Not in Pancreas Cancer Patients;Life;2023-11-28
2. Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer;Exploration of Targeted Anti-tumor Therapy;2023-02-28
3. Diagnosis of echinococcosis by detecting circulating cell-free DNA and miRNA;Expert Review of Molecular Diagnostics;2023-02-01
4. Liquid biopsy and preclinical tools for advancing diagnosis and treatment of patients with pancreatic neuroendocrine neoplasms;Critical Reviews in Oncology/Hematology;2022-12
5. Overview of liquid biopsy;Liquid Biopsy in Urogenital Cancers and its Clinical Utility;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3